Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic disease
Journal of The Royal Society Interface · 2023
DOI: 10.1098/rsif.2023.0247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Royal Society Interface, 2023. Verfasst von Chadi M Saad-Roy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: C3.ai Digital Transformation Institute and Microsoft Corporation, a gift from Google, LLC, James S. McDonnell Foundation.
Abstract (Originalsprache)
As the SARS-CoV-2 trajectory continues, the longer-term immuno-epidemiology of COVID-19, the dynamics of Long COVID, and the impact of escape variants are important outstanding questions. We examine these remaining uncertainties with a simple modelling framework that accounts for multiple (antigenic) exposures via infection or vaccination. If immunity (to infection or Long COVID) accumulates rapidly with the valency of exposure, we find that infection levels and the burden of Long COVID are markedly reduced in the medium term. More pessimistic assumptions on host adaptive immune responses illustrate that the longer-term burden of COVID-19 may be elevated for years to come. However, we also find that these outcomes could be mitigated by the eventual introduction of a vaccine eliciting robust (i.e. durable, transmission-blocking and/or ‘evolution-proof’) immunity. Overall, our work stresses the wide range of future scenarios that still remain, the importance of collecting real-world epidemiological data to identify likely outcomes, and the crucial need for the development of a highly effective transmission-blocking, durable and broadly protective vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
- Miller Institute for Basic Research in Science, University of California, Berkeley, CA, USA.
- Department of Integrative Biology, University of California, Berkeley, CA, USA.
- Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.
- Department of Epidemiology, Brown University, Providence, RI, USA.
- Institute at Brown for Environment and Society, Brown University, Providence, RI, USA.
ORCID-Profile: Chadi M Saad-Roy, Andrea L Graham, Simon A Levin, Caroline E Wagner, C Jessica E Metcalf
Förderung
- C3.ai Digital Transformation Institute and Microsoft Corporation
- a gift from Google, LLC
- James S. McDonnell Foundation
- National Science Foundation
- Adolph C. and Mary Sprague Miller Institute for Basic Research in Science, University of California Berkeley
- Natural Sciences and Engineering Research Council of Canada
- Flu Lab
- Princeton University
Zitieren
APA
Saad-Roy, C. M., Morris, S. E., Baker, R. E., Farrar, J., Graham, A. L., Levin, S. A., Wagner, C. E., Metcalf, C. J. E., & Grenfell, B. T. (2023). Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic disease. Journal of The Royal Society Interface. https://doi.org/10.1098/rsif.2023.0247
Vancouver
Saad-Roy CM, Morris SE, Baker RE, Farrar J, Graham AL, Levin SA, et al. Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic disease. Journal of The Royal Society Interface. 2023. doi:10.1098/rsif.2023.0247
BibTeX
@article{SaadRoy2023,
author = {Saad-Roy, Chadi M and Morris, Sinead E and Baker, Rachel E and Farrar, Jeremy and Graham, Andrea L and Levin, Simon A and Wagner, Caroline E and Metcalf, C Jessica E and Grenfell, Bryan T},
title = {Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic disease},
journal = {Journal of The Royal Society Interface},
year = {2023},
doi = {10.1098/rsif.2023.0247}
}
EUVIMED